Results 41 to 50 of about 68,366 (207)

Fatal intoxication after oral ingestion of amphetamine: Two case reports

open access: yesForensic Science International: Synergy
Amphetamine is a stimulant that is abused worldwide and e.g. leads to hyperthermia [Brinkman et al., 2014], dizziness, insomnia, stomachaches and suppression of appetite [Callaway et al., 1994].
Evelyn Pawlik, Felix Mayer, Oliver Temme
doaj   +1 more source

Analysis of amphetamine and methamphetamine contents in seized tablets from Jazan, Saudi Arabia by liquid chromatography-mass spectroscopy (LC-MS/MS) and chemometric techniques

open access: yesSaudi Pharmaceutical Journal, 2020
A number of illegal amphetamine tablets were seized from three different cities of Jazan province of southern Saudi Arabia and were analyzed for amphetamine and methamphetamine contents using LC-MS/MS technique. Analyses were performed using a previously
Hassan A. Alhazmi   +9 more
doaj   +1 more source

Circadian melatonin profile in opium and amphetamine dependent patients: A preliminary study

open access: yesNeurobiology of Sleep and Circadian Rhythms, 2019
Aim: The aim of this study was to investigate the relationship between opium and amphetamine dependency with the serum melatonin levels in the presence of circadian rhythm sleep disorders (CRSD).
Habibolah Khazaie, MD   +3 more
doaj   +1 more source

Levo(-) amphetamine and dextro(+) amphetamine in the treatment of narcolepsy [PDF]

open access: yesJournal of Neurology, Neurosurgery & Psychiatry, 1973
The narcoleptic syndrome is a life-long and sometimes familial disorder in which there is a disturbance of the rapid eye movement phase of sleep. Patients with periodic sleep in the daytime but no other symptoms seldom develop the narcoleptic syndrome and have a separate unrelated disorder.
J D, Parkes, G W, Fenton
openaire   +2 more sources

Amphetamine-induced locomotor activity in GIT1 deficient mice.

open access: yes, 2018
GIT1 WT (black circle) and GIT1 KO (open square) mice on a mixed genetic background were habituated to the locomotor chamber for 60 min prior to amphetamine injection.
Amanda C. Martyn (777373)   +7 more
core   +1 more source

Amphetamine-induced psychosis - a separate diagnostic entity or primary psychosis triggered in the vulnerable?

open access: yesBMC Psychiatry, 2012
Use of amphetamine and methamphetamine is widespread in the general population and common among patients with psychiatric disorders. Amphetamines may induce symptoms of psychosis very similar to those of acute schizophrenia spectrum psychosis.
Bramness Jørgen G   +8 more
doaj   +1 more source

Amphetamine-Induced Displacement of [11C]FLB 457 Binding Potential.

open access: yes, 2016
The bar graph shows [11C]FLB 457 BPND under baseline (white bars) and post-amphetamine (black bars) conditions in n = 31 healthy subjects. Amphetamine led to a significant decrease in five of the eight cortical regions of interest (* denotes p 9–11].
Maureen A. May (2847386)   +7 more
core   +1 more source

Amphetamine-Related Fatalities and Altered Brain Chemicals: A Preliminary Investigation Using the Comparative Toxicogenomic Database

open access: yesMolecules, 2023
Amphetamine is a psychostimulant drug with a high risk of toxicity and death when misused. Abuse of amphetamines is associated with an altered organic profile, which includes omega fatty acids.
Murad Tumayhi   +9 more
doaj   +1 more source

Effect of ifenprodil and cyproheptadine treatments on the d-amphetamine-induced sensitization.

open access: yes, 2016
Session 1: all groups received two saline administrations, 15 min and 30 min after being placed in the actimeter. Then, all amphetamine groups are treated with amphetamine (2 mg/kg) as indicated in materials and methods. Sessions 2 and 7: groups received
Alain Puech (3181143)   +5 more
core   +1 more source

The role of BDNF/TrkB signaling in acute amphetamine-induced locomotor activity and opioid peptide gene expression in the rat dorsal striatum

open access: yesFrontiers in Systems Neuroscience, 2011
Exposure to psychostimulants increases brain-derived neurotrophic factor (BDNF) mRNA and protein levels in the cerebral cortex and subcortical structures.
Jacqueline F McGinty   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy